Published in Am J Prev Med on September 01, 2013
The Affordable Care Act and Expanded Insurance Eligibility Among Nonelderly Adult Cancer Survivors. J Natl Cancer Inst (2015) 0.84
Annual Medical Expenditure and Productivity Loss Among Colorectal, Female Breast, and Prostate Cancer Survivors in the United States. J Natl Cancer Inst (2015) 0.81
Employment implications of informal cancer caregiving. J Cancer Surviv (2016) 0.78
Medicaid expansion and access to care among cancer survivors: a baseline overview. J Cancer Surviv (2015) 0.77
Preventive care receipt and office visit use among breast and colorectal cancer survivors relative to age- and gender-matched cancer-free controls. J Cancer Surviv (2014) 0.77
Access to Cancer Care and General Medical Care Services Among Cancer Survivors in the United States: An Analysis of 2011 Medical Expenditure Panel Survey Data. Public Health Rep (2016) 0.75
Medicaid Disenrollment and Disparities in Access to Care: Evidence from Tennessee. Health Serv Res (2016) 0.75
Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst (2011) 10.29
Predictive margins with survey data. Biometrics (1999) 9.18
Sicker and poorer--the consequences of being uninsured: a review of the research on the relationship between health insurance, medical care use, health, work, and income. Med Care Res Rev (2003) 5.46
Under use of necessary care among cancer survivors. Cancer (2004) 5.31
Access to medical care in the U.S.: realized and potential. Med Care (1978) 4.56
NCCN Clinical Practice Guidelines in Oncology: colon cancer. J Natl Compr Canc Netw (2009) 4.41
Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol (2003) 4.24
Health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol (2005) 4.10
Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst (2004) 3.74
Comparing care for breast cancer survivors to non-cancer controls: a five-year longitudinal study. J Gen Intern Med (2009) 2.36
The lifetime distribution of health care costs. Health Serv Res (2004) 1.98
Forgoing medical care because of cost: assessing disparities in healthcare access among cancer survivors living in the United States. Cancer (2010) 1.85
Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med (2007) 1.65
Cancer screening practices among cancer survivors. Am J Prev Med (2005) 1.29
Racial differences in the receipt of bowel surveillance following potentially curative colorectal cancer surgery. Health Serv Res (2003) 1.27
Burden of illness in adult survivors of childhood cancers: findings from a population-based national sample. Cancer (2010) 1.26
Health maintenance and screening in breast cancer survivors in the United States. Cancer Detect Prev (2006) 1.22
USPSTF perspective on evidence-based preventive recommendations for children. Pediatrics (2012) 1.20
Screening practices in cancer survivors. J Cancer Surviv (2007) 1.14
Second primary cancers: an overview. Hematol Oncol Clin North Am (2008) 1.11
Cancer survivorship care: exploring the role of the general internist. J Gen Intern Med (2009) 1.06
The use of preventive health services among elderly uterine cancer survivors. Am J Obstet Gynecol (2008) 1.05
Impact of survivorship-based research on defining clinical care guidelines. Cancer Epidemiol Biomarkers Prev (2011) 0.97
Medicaid enrollment at early stage of disease: the Breast and Cervical Cancer Prevention and Treatment Act in Georgia. Inquiry (2011) 0.88
Second primary cancers in survivors of childhood cancer. Lancet (2009) 0.87
American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol (2007) 4.45
Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol (2005) 4.10
Health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol (2005) 4.10
Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol (2007) 3.91
Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer. J Thorac Oncol (2013) 3.67
Breast cancer as a global health concern. Cancer Epidemiol (2009) 2.71
The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care. Cancer (2010) 2.63
Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base. Eur Urol (2012) 2.61
Surveillance of demographic characteristics and health behaviors among adult cancer survivors--Behavioral Risk Factor Surveillance System, United States, 2009. MMWR Surveill Summ (2012) 2.57
Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer. Cancer (2006) 2.42
Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev (2008) 1.95
Cervical cancer screening rates in the United States and the potential impact of implementation of screening guidelines. CA Cancer J Clin (2007) 1.77
Racial and ethnic variations in incidence and survival of cutaneous melanoma in the United States, 1999-2006. J Am Acad Dermatol (2011) 1.76
The economic burden of HIV in the United States in the era of highly active antiretroviral therapy: evidence of continuing racial and ethnic differences. J Acquir Immune Defic Syndr (2006) 1.71
Developing and testing a cost-assessment tool for cancer screening programs. Am J Prev Med (2009) 1.67
Prostate cancer screening in men ages 75 and older fell by 8 percentage points after Task Force recommendation. Health Aff (Millwood) (2013) 1.63
Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States. Vaccine (2012) 1.61
Cervical cancer screening among women in metropolitan areas of the United States by individual-level and area-based measures of socioeconomic status, 2000 to 2002. Cancer Epidemiol Biomarkers Prev (2006) 1.51
Years of potential life lost caused by prostate cancer deaths in the United States-Projection from 2004 through 2050. Cancer Epidemiol (2010) 1.49
The cost-effectiveness of male HPV vaccination in the United States. Vaccine (2011) 1.48
American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer. J Clin Oncol (2004) 1.44
Melanoma survival in the United States, 1992 to 2005. J Am Acad Dermatol (2011) 1.44
Economic burden of cancer survivorship among adults in the United States. J Clin Oncol (2013) 1.41
Years of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: a systematic review of the literature. Pharmacoeconomics (2011) 1.41
Host factors associated with the Sindbis virus RNA-dependent RNA polymerase: role for G3BP1 and G3BP2 in virus replication. J Virol (2010) 1.38
Cost-effectiveness of human papillomavirus vaccination in the United States. Emerg Infect Dis (2008) 1.35
The Medical Expenditure Panel Survey (MEPS) experiences with cancer survivorship supplement. J Cancer Surviv (2012) 1.31
Outcome after colectomy for Clostridium difficile colitis. Dis Colon Rectum (2004) 1.31
Dietary intake estimates in the National Health Interview Survey, 2000: methodology, results, and interpretation. J Am Diet Assoc (2005) 1.29
The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity-United States, 2000 to 2006. J Am Acad Dermatol (2011) 1.28
Active transportation increases adherence to activity recommendations. Am J Prev Med (2006) 1.28
Burden of illness in adult survivors of childhood cancers: findings from a population-based national sample. Cancer (2010) 1.26
Preliminary treatment considerations among men with newly diagnosed prostate cancer. Am J Manag Care (2010) 1.24
Estimated effects of the National Breast and Cervical Cancer Early Detection Program on breast cancer mortality. Am J Prev Med (2011) 1.21
Association of cutaneous melanoma incidence with area-based socioeconomic indicators-United States, 2004-2006. J Am Acad Dermatol (2011) 1.20
Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006. J Am Acad Dermatol (2011) 1.20
Physician preferences and attitudes regarding different models of cancer survivorship care: a comparison of primary care providers and oncologists. J Cancer Surviv (2013) 1.18
Medical costs and productivity losses of cancer survivors--United States, 2008-2011. MMWR Morb Mortal Wkly Rep (2014) 1.18
On the importance of race, socioeconomic status and comorbidity when evaluating quality of life in men with prostate cancer. J Urol (2007) 1.14
Follow-up of colorectal cancer patients after resection with curative intent-the GILDA trial. Surg Oncol (2004) 1.14
Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions. World J Urol (2010) 1.12
Cancer screening and risk factor rates among American Indians. Am J Public Health (2005) 1.12
Morbidity and mortality of gastrectomy for cancer in Department of Veterans Affairs Medical Centers. Surgery (2002) 1.11
From the guest editors: introduction for the impact of health care reform on cancer patients. Cancer J (2010) 1.08
State-level projections of cancer-related medical care costs: 2010 to 2020. Am J Manag Care (2012) 1.06
Cholecystectomy in patients with prior ventriculoperitoneal shunts. Am J Surg (2011) 1.05
Insurance status and survival disparities among nonelderly rectal cancer patients in the National Cancer Data Base. Cancer (2010) 1.04
Patient-centered care categorization of U.S. health care expenditures. Health Serv Res (2010) 1.03
Appendectomy for appendicitis in patients with schizophrenia. Am J Surg (2007) 1.03
Association of insurance status and age with cervical cancer stage at diagnosis: National Cancer Database, 2000-2007. Am J Public Health (2012) 1.02
Risk factors for adverse outcomes following surgery for small bowel obstruction. Ann Surg (2006) 1.02
Risk factors for adverse outcomes after the surgical treatment of appendicitis in adults. Ann Surg (2003) 1.02
Preventing cervical cancer : overviews of the National Breast and Cervical Cancer Early Detection Program and 2 US immunization programs. Cancer (2008) 1.02
Explaining variation across grantees in breast and cervical cancer screening proportions in the NBCCEDP. Cancer Causes Control (2015) 1.01
Comparison of SEER Treatment Data With Medicare Claims. Med Care (2016) 1.01
Cost of cervical cancer treatment: implications for providing coverage to low-income women under the Medicaid expansion for cancer care. Womens Health Issues (2010) 1.00
Public health national approach to reducing breast and cervical cancer disparities. Cancer (2014) 0.99
Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer. BJU Int (2011) 0.98
Surveillance of patients with breast cancer after curative-intent primary treatment: current practice patterns. J Oncol Pract (2011) 0.97
Hemipelvectomy for severe decubitus ulcers in patients with previous spinal cord injury. Am J Surg (2003) 0.97
Costs of follow-up after potentially curative treatment for extremity soft-tissue sarcoma. Int J Oncol (2004) 0.97
Implementation and success of nurse telephone counseling in linguistically isolated Korean American patients with high blood pressure. Patient Educ Couns (2009) 0.96
Identifying and controlling for program-level differences in comparative cost analysis: lessons from the economic evaluation of the National Breast and Cervical Cancer Early Detection Program. Eval Program Plann (2008) 0.96
Comparison of angioplasty and surgery for neonatal aortic coarctation. Ann Thorac Surg (2005) 0.95
Characteristics of US counties with no mammography capacity. J Community Health (2012) 0.94
Overview of the CDC Cervical Cancer (Cx3) Study: an educational intervention of HPV testing for cervical cancer screening. J Womens Health (Larchmt) (2013) 0.93
Melanoma treatment costs: a systematic review of the literature, 1990-2011. Am J Prev Med (2012) 0.93
Fontan operation: a comparison of lateral tunnel with extracardiac conduit. Ann Thorac Surg (2007) 0.92
The impact of a national program to provide free mammograms to low-income, uninsured women on breast cancer mortality rates. Cancer (2010) 0.92
Economies of scale in federally-funded state-organized public health programs: results from the National Breast and Cervical Cancer Early Detection Programs. Health Care Manag Sci (2013) 0.92
A microfluidic device for characterizing the invasion of cancer cells in 3-D matrix. Electrophoresis (2009) 0.92
Appendectomy for appendicitis in patients with a prior ventriculoperitoneal shunt. J Surg Res (2007) 0.91
Repeat pap testing and colposcopic biopsies in the underserved. Obstet Gynecol (2009) 0.90
Years of potential life lost and productivity losses from male urogenital cancer deaths--United States, 2004. Urology (2010) 0.90
Coherence and completeness of population-based family cancer reports. Cancer Epidemiol Biomarkers Prev (2010) 0.89
Follow-up for patients with colorectal cancer after curative-intent primary treatment. J Clin Oncol (2004) 0.89
Depression increases risk of incident myocardial infarction among Veterans Administration patients with rheumatoid arthritis. Gen Hosp Psychiatry (2009) 0.89
Long-term management of patients after potentially curative treatment of extremity soft tissue sarcoma: practice patterns of members of the Society of Surgical Oncology. Surg Oncol (2005) 0.88
Patterns of disease and surgical treatment among United States veterans more than 50 years of age with ulcerative colitis. Am J Surg (2003) 0.88
Isolation and characterization of Pseudomonas brassicacearum J12 as an antagonist against Ralstonia solanacearum and identification of its antimicrobial components. Microbiol Res (2012) 0.88
Trends in abnormal cancer screening results in the United States of America. J Med Screen (2007) 0.88
A class of novel carboline intercalators: Their synthesis, in vitro anti-proliferation, in vivo anti-tumor action, and 3D QSAR analysis. Bioorg Med Chem (2010) 0.88
Lost productivity and burden of illness in cancer survivors with and without other chronic conditions. Cancer (2013) 0.88
Oncologists' and primary care physicians' awareness of late and long-term effects of chemotherapy: implications for care of the growing population of survivors. J Oncol Pract (2013) 0.88
The impact of detection and treatment on lifetime medical costs for patients with precancerous polyps and colorectal cancer. Health Econ (2009) 0.87
Cost of breast cancer treatment in Medicaid: implications for state programs providing coverage for low-income women. Med Care (2011) 0.87
A systematic review of large-scale surveys of cancer survivors conducted in North America, 2000-2011. J Cancer Surviv (2012) 0.87
Annual patient time costs associated with medical care among cancer survivors in the United States. Med Care (2014) 0.86